Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$0.62 - $1.0 $182 - $295
295 Added 1.97%
15,235 $10,000
Q3 2023

Nov 14, 2023

BUY
$0.47 - $0.9 $185 - $355
395 Added 2.72%
14,940 $9,000
Q2 2023

Aug 14, 2023

SELL
$0.38 - $1.09 $576 - $1,653
-1,517 Reduced 9.44%
14,545 $12,000
Q1 2023

May 09, 2023

BUY
$0.42 - $0.75 $1,953 - $3,488
4,651 Added 40.76%
16,062 $7,000
Q4 2022

Feb 10, 2023

SELL
$0.54 - $9.8 $1,204 - $21,863
-2,231 Reduced 16.35%
11,411 $7,000
Q3 2022

Nov 10, 2022

BUY
$0.13 - $12.4 $710 - $67,778
5,466 Added 66.85%
13,642 $10,000
Q2 2022

Aug 15, 2022

BUY
$1.11 - $3.46 $7,153 - $22,299
6,445 Added 372.33%
8,176 $12,000
Q1 2022

May 12, 2022

BUY
$1.78 - $8.5 $295 - $1,411
166 Added 10.61%
1,731 $7,000
Q4 2021

Feb 14, 2022

BUY
$7.3 - $11.24 $11,424 - $17,590
1,565 New
1,565 $12,000

Others Institutions Holding SABS

About SAB Biotherapeutics, Inc.


  • Ticker SABS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,030,900
  • Market Cap $172M
  • Description
  • SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases ...
More about SABS
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.